|
Session 69
Poster Abstracts
Neuropathogenesis: Clinical Correlates and Observational Studies
Wednesday, 1:30 - 3:30 pm
Poster Hall |
| 351 |
The Predictors of HIV Encephalopathy and Outcome in HIV+ Patients in the Era of Effective Therapy
C Mussini1, K Bhaskaran2, S Walker2, M Dorrucci3, C Sabin4, A Phillips4, Kholoud Porter*2, and CASCADE Collaboration
1Clin of Infectious and Tropical Diseases, Modena, Italy; 2Med Res Council Clin Trials Unit, London, UK; 3Inst Superiore di Sanitŕ, Rome, Italy; and 4Royal Free and Univ Coll Med Sch, London, UK |
| 352 |
HIV DNA Correlates with HIV-1-associated Dementia in ART-naive Patients
Bruce Shiramizu*1, S Nidhinandana2, P Sithinamsuwan2, W Apateerapong1, S Ratto-Kim1,3, G Watt1, K Robertson4, R Paul5, C Shikuma1, V Valcour1, and South East Asia Research Collaboration with Hawaii (SEARCH)
1Univ of Hawaii, John A Burns Sch of Med, Honolulu, US; 2Phramongkutklao Med Ctr, Bangkok, Thailand; 3Armed Forces Res Inst of the Med Sci, Bangkok, Thailand; 4Univ of North Carolina at Chapel Hill, US; and 5Brown Med Sch, Miriam Hosp, Providence, RI, US |
| 353 |
CD4 Count and Risk of HIV-related Cognitive Dysfunction in the Era of ART
Robert Paul*, K Tashima, D Tate, K Coop, V Valcour, T Flanigan, and C Carpenter
Brown Univ, Providence, RI, US |
| 354 |
Factors Associated with Persistent Neurocognitive Impairment Despite Long-term HAART in Patients with HIV Dementia
Valerio Tozzi*, P Balestra, M Salvatori, C Vlassi, A Corpolongo, R Bellagamba, S Galgani, P Lorenzini, A Antinori, and P Narciso
Natl Inst of Infectious Diseases, L Spallanzani, Rome, Italy |
355
 |
Central Nervous System Immune Activation Is Still Present after More than 4 Years of Effective HAART
Arvid Edén*1, R Price2, S Spudich2, D Fuchs3, L Hagberg1, and M Gisslén1
1Sahlgrenska Akademy, Göteborg Univ, Sweden; 2Univ of California, San Francisco, US; and 3Univ of Innsbruck, Austria |
356
|
Intrathecal Immune Activation Is Reduced in Treated Subjects Failing ART
Serena Spudich*1, N Lollo1, B Chang2, and R Price1
1Univ of California, San Francisco, US and 2San Francisco Gen Hosp, CA, US |
357
|
Predictive Indicators of Disease Progression in HAART-treated Patients with HIV-related Leukoencephalopathies
Serena Delbue*1, M Saresella1, E Marchioni2, F Guerini1, I Marventano1, G Spoladore3, G Sotgiu4, M Schifino2, R Maserati3, and P Ferrante1
1Don Carlo Gnocchi Fndn ONLUS, IRCCS, Milan, Italy; 2Mondino Hosp, IRCCS, Pavia, Italy; 3Policin San Matteo, Pavia, Italy; and 4Hygiene and Preventive Med Inst, Univ of Sassari Med Sch, Italy |
| 358 |
Stability of CNS Disease in HIV-infected Children during the HAART Era
P Wolters1,2, S Martin1,2, M Toledo-Tamula1,2, S Zeichner2, L Civitello2,3, and Rohan Hazra*2
1Medical Illness Counseling Ctr, Chevy Chase, MD, US; 2NCI, NIH, DHHS, Bethesda, MD, US; and 3Children's Natl Med Ctr, Washington, DC, US |
|
